BonTriage

Name

BonTriage

Legal name

BonTriage, Inc.

Website

https://bontriage.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Digital Health / Clinical Assessment Software

NAICS

Other Computer Related Services (541519), Offices of Physicians, Mental Health Specialists (621112)

SIC

Services-Prepackaged Software (7372), Services-Management Consulting Services (8742)

akta.pro primary industry

Headache & Migraine Medicine (HLAKAIAE)

akta.pro secondary industry

Ambulatory & Physician Practice EHRs (HLACAAAB)

Keywords

• Headache assessment software
• Migraine monitoring app
• Clinical decision support
• Patient intake software
• Digital health platform

Headquarters

HQ city

Oxnard

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Patient Assessment Services: Revenue generated from patients completing headache assessments and receiving AI-generated clinical reports to share with their healthcare providers.
2. Clinical Trial Tools for Pharma/Device Companies: BonTriage provides tools to pharmaceutical and medical device companies to decrease screen failure rates and improve adherence during clinical trials, along with app-based data collection and analytics.
3. Workplace Headache Analysis Services: Services for self-insured companies, HMOs, and healthcare management organizations including workplace analysis and education to reduce absenteeism and presenteeism caused by disabling headaches.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels4 records

Core offering

BonTriage provides an AI-powered headache assessment platform consisting of a detailed online questionnaire that patients complete in under an hour to generate a Level 5 clinical impression report for their physician, the Migraine Mentor mobile app for ongoing real-time headache monitoring and trigger identification, and separate enterprise offerings including clinical-trial tools for pharmaceutical/medical device companies and workplace headache analysis for self-insured employers and HMOs.

Product overview

BonTriage is a healthcare technology company offering a unified headache management platform consisting of an AI-powered assessment questionnaire (BonTriage Assessment) that generates clinical impression reports for physicians, and the Migraine Mentor mobile app for ongoing patient monitoring and trigger identification. The platform is designed for people with headaches, doctors who treat headache, pharmaceutical/medical device companies, and payors.

Differentiator

Problem solved

Functional benefit

Products and services

• BonTriage Assessment Questionnaire

Quantifiable outcome

• Questionnaire completion in under one hour generates comprehensive headache report

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature4 records

Scale indicators1 record

Recent moves3 records

Expansion highlights5 records

Broad incumbents

• Teladoc Health (including Livongo): Teladoc operates large-scale virtual care platforms and chronic condition management (via Livongo). It is a broad incumbent with overlapping capability in patient-reported outcomes, chronic condition tracking, and payor distribution — categories where BonTriage also competes.
• Omada Health: Omada Health is a digital chronic care platform sold to employers and health plans, offering coaching and tracking for diabetes, hypertension, and musculoskeletal conditions. It overlaps with BonTriage's payor/employer workplace health distribution motion and recurring B2B2C model.
• Medidata (Dassault Systèmes): Medidata is the dominant clinical trial technology platform, offering eCOA, randomization, and patient engagement tools used by pharma. It overlaps with BonTriage's pharma clinical trial offering (adherence, data collection, screen-failure reduction) but serves all therapeutic areas.
• Hims & Hers Health: Hims & Hers operates a large consumer telehealth and digital health platform that includes migraine treatment. It competes with BonTriage in the consumer-direct headache care category but serves a far broader set of conditions and includes prescribing/drug delivery.

Direct peers

• Curelator (Healint): Healint operates Migraine Buddy, the most widely used migraine tracking and trigger-identification app globally. It is a direct competitor to BonTriage's Migraine Mentor app on the consumer headache-tracking side and overlaps on data-driven headache analytics for pharma research.
• Neura Health: Neura Health is a telehealth and care-coordination platform specializing in headache and migraine, combining neurologist consultations with digital tracking tools. It overlaps directly with BonTriage's physician-facing headache workflow and patient monitoring capabilities.
• THREAD Research: THREAD provides decentralized clinical trial technology, including eCOA, patient apps, and remote data capture for pharma. It directly competes with BonTriage's clinical trial app and data collection offering to pharma/device sponsors.
• Cove (Thirty Madison): Cove is a digital migraine clinic offering telehealth consultations with headache specialists, prescription management, and ongoing tracking. It is a direct peer in the patient-to-headache-specialist telehealth pathway, though Cove leans more on prescription delivery.

Emerging players

• Pear Therapeutics (legacy /破产 assets): Pear Therapeutics pioneered prescription digital therapeutics (PDTs) with FDA authorization. While Pear itself has wound down, the prescription digital therapeutics category it defined represents the regulatory pathway BonTriage could follow if its headache diagnostic tools are ever classified as SaMD.
• Akili Interactive: Akili develops FDA-cleared digital therapeutics for cognitive and neurological conditions. It is comparable as a digital-health company targeting neurology with regulatory-cleared software, though Akili focuses on cognitive disorders rather than headache specifically.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BonTriage